 |
Printer Friendly
Printed from http://www.researchandmarkets.com/reports/891
Niche Cancers 2001: Acute Myeloid Leukemia
|
Description: |
Disease Overview - incidence, classification and diagnosis * Market Analysis - global sales and profiles of individual drugs currently on the market * Unmet Needs - unmet needs associated with current drug therapies, the characteristics needed to offer superior treatment and the projected direction of future R&D activity * Pipeline * Analysis - R&D pipeline, with profiles of the key drugs in development * Market * Forecasts - future trends in the incidence of each cancer type and drug sales forecasts to 2007 |
|
Contents: |
TABLE OF CONTENTS
EXECUTIVE SUMMARY
INTRODUCTION
Disease overview
Acute Myeloid Leukemia
Epidemiology
Risk factors
DIAGNOSIS AND TREATMENT OF AML
Diagnosis and Staging
Treatment of AML
Overview
Stage specific breakdown of treatment
Remission therapy for AML
Country Analysis of current treatment practice
MARKET CONTEXT
Currently approved drugs
Cytarabine
Daunorubicin
Idamycin (idarubicin)
Mylotarg (gemtuzumab ozogamicin)
Cost of AML treatment
UNMET NEEDS IN AML
AML PIPELINE
Gleevac (STI 571)
Proleukin (Aldesleukin)
Ceplene (Histamine dihydrochloride)
SMART HuM195
Troxatyl (troxacitabine)
Annamycin
DX-8951f
Irofulven
Others
THE FUTURE DECODED
Future incidence of AML
Trends in the cancer market to 2007
The niche cancer market
Market forecast for AML pipeline
References
|
|
Ordering: |
Order Online - visit http://www.researchandmarkets.com/reports/891
Order by Fax - using the order form below
Order By Post - print the order form below and send to
 |
Research and Markets,
Guinness Centre,
Taylors Lane,
Dublin 8,
Ireland.
|
|
|
 |
Page 1 of 2 Printed 29/11/2009 21:01:36 |
|
Fax Order Form
To place an order via fax simply print this form, fill in the information below and
fax the completed form to
646-607-1907 (from USA) or +353 1 6849977 (from Rest of World). If you have any questions please email help@researchandmarkets.net
Order information
Please verify that the product information is correct and select the format you require.
|
|
|
Product Name: |
Niche Cancers 2001: Acute Myeloid Leukemia
|
|
Web Address: |
http://www.researchandmarkets.com/reports/891
|
|
Office Code: |
|
OC8HJNPOUMUXU
|
Report formats
Please enter the quantity of the report format you require.
|
|
Format
|
Quantity
|
Price
|
|
Hard Copy
|
|
€2,794.00 + EUR€ 50.00 Shipping/Handling *
|
|
Electronic
|
|
€2,552.00
|
* Shipping/Handling is only charged once per order.
Contact information
Please enter all the information below in BLOCK CAPITALS.
 |
|
First Name: |
Last Name: |
|
Email Address: |
 |
|
Job Title: |
 |
|
Organisation: |
 |
|
Address: |
 |
|
City: |
 |
|
Postal/Zip Code: |
 |
|
Country: |
 |
|
Phone Number: |
 |
|
Fax Number: |
 |
|
Please fax this form to: (646) 607-1907 or (646) 964-6609 (from USA) +353-1-481-1716 or +353-1-653-1571 (from Rest of World)
 |
Page 2 of 2 Printed 29/11/2009 21:01:36
|
|
Payment information
Please indicate the payment method you would like to use by selecting the appropriate
box.
|
|
|
|
American Express
|
|
Diners Club
|
|
Master Card
|
|
Visa
|
|
|
|
 |
|
Cardholder's Name: |
 |
|
|
|
Cardholder's Signature: |
 |
|
|
|
Expiry Date: |
/  |
|
|
|
Card Number: |
 |
|
|
|
CVV Security Code: |
 |
|
|
|
Issue Date: |
/ (Diners
Club only)
|
|
|
|
 |
Please post the check, accompanied by this form, to:
Research and Markets,
Guinness Centre,
Taylors Lane,
Dublin 8,
Ireland.
|
|
 |
|
 |
Please transfer funds to:
 |
|
Account number: |
83313083 |
|
Sort code: |
98-53-30 |
|
Swift code: |
ULSBIE2D |
|
IBAN number: |
IE78ULSB98533083313083 |
|
Bank Address: |
Ulster Bank,
27-35 Main St,
Blackrock,
Co. Dublin,
Ireland. |
|
|
|
If you have a Marketing Code please enter it below:
|
|
|
Marketing Code: |
 |
|
Please note that by ordering from Research and Markets you are agreeing to our Terms and Conditions at http://www.researchandmarkets.com/info/terms.asp
|
|
Please fax this form to: (646) 607-1907 or (646) 964-6609 (from USA) +353-1-481-1716 or +353-1-653-1571 (from Rest of World)
|
 |
 |
|
|